Ariel M. Rubinstein

Hebrew University of Jerusalem — Israel

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index1.8kcitations57works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Proteoglycans and glycosaminoglycans research(19), Fibroblast Growth Factor Research(19), Computational Drug Discovery Methods(9), Lung Cancer Treatments and Mutations(9), Cancer Genomics and Diagnostics(9)

Publications57 total

Effective head and neck cancer treatment combines radiation and local extended cisplatin release
Journal of Controlled Release·2025· 1 cited
375 (PB363): Investigating cell-cell communication in glioblastoma: implications for radiotherapy resistance and therapeutic strategies
European Journal of Cancer·2024
389 (PB377): Sensitization to carboplatin chemotherapy by decoding intra tumor heterogeneity in triple negative breast cancer
European Journal of Cancer·2024
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer
Molecular Cancer·2024· 11 citedOpen Access
Supplementary Data from Heparanase Accelerates Obesity-Associated Breast Cancer Progression
2023Open Access
Data from Heparanase Accelerates Obesity-Associated Breast Cancer Progression
2023Open Access
Data from Heparanase Accelerates Obesity-Associated Breast Cancer Progression
2023Open Access
Supplementary Data from Heparanase Accelerates Obesity-Associated Breast Cancer Progression
2023Open Access
Supplementary Figures from Heparanase Accelerates Obesity-Associated Breast Cancer Progression
2023Open Access
Supplementary Figures from Heparanase Accelerates Obesity-Associated Breast Cancer Progression
2023Open Access
Supplementary Table 1 from Heparanase Accelerates Obesity-Associated Breast Cancer Progression
2023Open Access
Supplementary Table 1 from Heparanase Accelerates Obesity-Associated Breast Cancer Progression
2023Open Access
Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase
Biomedicines·2023· 3 citedOpen Access
Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance
Genome Medicine·2022· 17 citedOpen Access
Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma
Cells·2022· 11 citedOpen Access
Additional file 3 of Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance
Figshare·2022Open Access
Additional file 4 of Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance
Figshare·2022Open Access
Additional file 5 of Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance
Figshare·2022Open Access
Additional file 6 of Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance
Figshare·2022Open Access
Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes
Theranostics·2022· 19 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Michael Elkin(19), Amichay Meirovitz(18), Esther Hermano(15), Nataly Kravchenko‐Balasha(15), Israël Vlodavsky(11), Swetha Vasudevan(10), Heba Alkhatib(10), Tamar Peretz(9), Amir Sonnenblick(9), Sangita Roy Chowdhury(9), Shira Stefansky(9), Efrat Flashner-Abramson(9), Jin‐Ping Li(8), Johan van der Vlag(8), Tamar Peretz-Yablonsky(8), Avital Granit(8), Kim Sheva(8), Bella Maly(7), Daniela Nahmias(7), Solomon Oguche(7)